ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

Name: ATAI Life Sciences N.V.: Is Infosys Ltd. worth buying?
Item: ATAI Life Sciences N.V.
Rating: 1.53650
Author: Trendlyne DVM scores

about

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant de...

4.00 -0.13 (-3.15%)

40.74% Fall from 52W High

5.1M

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for ATAI Life Sciences N.V. is on 20 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

4.0 / 100

Technically Neutral

57.5 / 100

1Yr Price target upside is 203%

9 analysts

ATAI Life Sciences NV Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ATAI Life Sciences N.V. Live Stock Price Today, Share Analysis and Chart

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant de...

40.74% Fall from 52W High

SWOT Analysis

ATAI Life Sciences NV Live Price Chart